Cocrystal Pharma (COCP) EBT (2010 - 2026)
Cocrystal Pharma (COCP) posted EBT of -$2.3 million for Q1 2026, down 1.52% sequentially from -$2.3 million in Q4 2025, and down 1.3% YoY from -$2.4 million in Q1 2025.
Cocrystal Pharma (COCP) EBT (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported EBT for 17 years, with the latest figure at -$2.3 million in Q1 2026.
- Quarterly EBT fell 1.3% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.3 million (up 51.65% YoY) and the FY2025 annual result came in at -$9.7 million, up 48.07% from the prior year.
- EBT slipped to -$2.3 million in Q1 2026 per COCP's latest filing, from -$2.3 million in the prior quarter.
- Over five years, EBT peaked at -$2.3 million in Q4 2025 and troughed at -$24.5 million in Q2 2022.
- A 5-year average of -$5.3 million and a median of -$4.5 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2023: EBT sank 529.45% in 2022, then soared 81.51% in 2023.
- Over 5 years, EBT stood at -$4.5 million in 2022, then grew by 0.36% to -$4.5 million in 2023, then increased by 11.35% to -$4.0 million in 2024, then soared by 42.19% to -$2.3 million in 2025, then dropped by 1.52% to -$2.3 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$2.3 million, -$2.3 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 81.49 Mn |
| 10 | Cocrystal Pharma | 16.41 Mn | 14.09 Mn | - | -3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.70 Mn |
| Mar 31, 2026 | -2.33 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -2.33 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -3.98 Mn |
| Sep 30, 2024 | -5.46 Mn |
| Jun 30, 2024 | -7.58 Mn |
| Mar 31, 2024 | -3.94 Mn |
| Dec 31, 2023 | -4.49 Mn |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -4.52 Mn |
| Mar 31, 2023 | -5.17 Mn |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | -5.71 Mn |
| Jun 30, 2022 | -24.45 Mn |
| Mar 31, 2022 | -4.69 Mn |
| Dec 31, 2021 | -3.70 Mn |
| Sep 30, 2021 | -4.01 Mn |